Objective
The objective is to check the efficacy and safety of two operative techniques
designed for treating morbidly obese patients: laparoscopic sleeve gastrectomy
(LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB).
Patients and methods
The study includes 72 morbidly obese patients, who were divided into two groups:
group A, 40 (55.5%) patients treated using LSG, whereas group B, 32 (44.5%)
patients managed by LRYGB. Operations were completed according to the rules
of laparoscopic surgery. Collected operative data included operative time,
intraoperative complications, postoperative (PO) complications, ICU, and
hospital stay. All patients were monitored throughout the first 2 PO years at 3rd,
6th, 12th, and 24th PO months.
Results
There is a significant difference between both groups regarding operative time. The
rates of early PO complications were higher in LRYGB than LSG group. Both groups
showed a significantweight loss at the first 12months postoperatively. ThemeanBMI
dropped from 39.5±3.03 to 33.10±3.56 kg/m2 among LSG patients compared with
40.18±3.18 to 30.23±2.64 kg among LRYGB patients. However, at the end of the
second PO year, no difference in patients’ weight, BMI, The percentage of excess
weight loss (%EWL), or EBMIL was noticed in both groups. At the end of the first PO
year, a dramatic improvement in both groups was seen about frequency and severity
of associated comorbidities except for gastroesophageal reflux disease.At the end of
the secondPOyear, all comorbidities showed prominent remissionamong patients of
LSG group. Patients of LRYGB showed complete resolution of type 2 diabetes
mellitus, obstructive sleep apnea, and depression.
Conclusion
Both LSG and LRYGB are safe bariatric surgical procedures that deliver convenient
outcomes in weight loss and resolution of most obesity-associated comorbidities. |
